| -Change In Other Working Capital |
-$11.43M |
-$239.98M |
$88.92M |
-$46.49M |
-$42.70M |
| Net cash flow from investing |
-$31.16M |
-$50.75M |
-$78.26M |
-$65.05M |
-$55.79M |
| -Change in Payables and Accrued Expense |
$779,000.00 |
-$44.60M |
$21.58M |
$5.73M |
$38.70M |
| -Change in Receivables |
$35.09M |
-$21.13M |
$41.18M |
$25.70M |
$16.95M |
| Change in Working Capital |
$24.44M |
-$305.70M |
$151.68M |
-$15.07M |
$12.95M |
| Other Non-Cash Items |
$766,000.00 |
$3.62M |
$475,000.00 |
$3.38M |
$15.81M |
| Deferred Tax |
-$19.93M |
-$2.59M |
-$42.16M |
-$49.01M |
-$31.72M |
| Depreciation & Depletion & Amortization |
$160.12M |
$159.37M |
$165.85M |
$168.56M |
$165.31M |
| Gain/Loss from Continuing Operations |
$9.19M |
$10.71M |
$1.29M |
$3.51M |
$3.83M |
| Net Income from Continuing Operations |
$55.28M |
$21.59M |
-$1.48B |
$88.11M |
$42.09M |
| Net cash flow from continuing operations |
$257.89M |
-$83.22M |
$344.22M |
$224.80M |
$236.54M |
| Operating Cash Flow |
$257.89M |
-$83.22M |
$344.22M |
$224.80M |
$236.54M |
| Free Cash Flow |
$209.72M |
-$137.12M |
$281.19M |
$159.75M |
$180.74M |
| Net Cash Flow from Continuing Investing Activities |
-$31.16M |
-$50.75M |
-$78.26M |
-$65.05M |
-$55.79M |
| Net PPE Purchase and Sale |
-$31.16M |
-$53.90M |
-$63.03M |
-$65.05M |
-$55.79M |
| Effect of Exchange Rate Changes |
-$6.89M |
$9.85M |
-$3.32M |
$8.45M |
$27.84M |
| Beginning Cash Balance |
$415.51M |
$521.13M |
$538.49M |
$535.13M |
$475.45M |
| Net Change in Cash |
$32.87M |
-$115.46M |
-$14.04M |
-$5.10M |
$31.84M |
| Ending Cash Balance |
$441.49M |
$415.51M |
$521.13M |
$538.49M |
$535.13M |
| Net Other Financing Charges |
-$7.76M |
-$18.31M |
$9.96M |
-$10.38M |
$4.36M |
| Proceeds from Stock Option Exercised |
$0.00 |
$2.41M |
-$13,000.00 |
$2.39M |
-$1,000.00 |
| Cash Dividends Paid |
-$23.07M |
-$23.15M |
-$23.23M |
-$21.87M |
-$22.14M |
| Net Common Stock Issuance |
-$1.29M |
-$45.89M |
-$72.20M |
-$41.77M |
-$46.82M |
| Net Issuance Payments Of Debt |
-$161.75M |
$103.44M |
-$194.53M |
-$93.21M |
-$84.30M |
| Net Cash Flow from Continuing Financing Activities |
-$193.87M |
$18.50M |
-$280.00M |
-$164.84M |
-$148.90M |
| Financing Cash Flow |
-$193.87M |
$18.50M |
-$280.00M |
-$164.84M |
-$148.90M |
| Net Business Purchase and Sale |
$0.00 |
$3.16M |
-$15.22M |
$0.00 |
$0.00 |
No comments yet — be the first to weigh in on CNXC.